All day and every day, some of the stock market's best and brightest traders and money managers share their ideas, insights and analysis in real-time on Minyanville's Buzz & Ban

Hewlett-Packard’s (HPQ) fourth-quarter earnings reflect its continued effort to expand through acquisition and deliver end-to-end data services.The company is scheduled to release earnings Mond

Should Goldman Sachs (GS) pay its vaunted legions of bankers and traders less money?According to the Wall Street Journal, some of the dominant global investment bank's major shareholders are answerin

The pharmaceutical landscape is rapidly changing as patents for some of the blockbuster drugs of the last decade near expiration and other players try to grab some of the remaining revenues before ge

Last month I highlighted the structural changes that have taken place in the DRAM industry and how that makes for a positive investment environment over the next year or so. Since then, there have be

Vivus (VVUS) is raising the bar on erectile dysfunction drugs, potentially becoming the latest formidable competitor to Viagra and Cialis in the $3.8 billion market. Investors in the California-based

Editor's Note: This article was written by energy journalist Philip H. de Leon of OilPrice.com, which offers free information and analysis on energy and commodities. The site has sections devoted to

A 40-year veteran of small-cap investing, Bill Nasgovitz never used to concern himself much with the broader macro picture of the US economy. A dedicated, bottoms-up value investor, Nasgovitz simply

The US Commerce Department said retail sales rose 1.4% in October, surpassing the forecast 0.9% increase, but look for downbeat numbers when Sears Holdings (SHLD) reports third-quarter earnings Thurs

Well, I finally got to watch The Taking of Pelham 123, which I'd fallen asleep during the night before. It's an awesome movie -- both Travolta and Denzel did a heck of a job. Asian stocks sank overni